The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRC2.L Regulatory News (RC2)

  • There is currently no data for RC2

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Results for 31 December 2015

29 Apr 2016 14:25

RNS Number : 8722W
Reconstruction Capital II Ltd
29 April 2016
 

29 April 2016

Reconstruction Capital II Limited (the "Company")

 

Annual Report and Audited Consolidated Financial Statements

for the year ended 31 December 2015

 

Reconstruction Capital II Limited ("RC2", the "Company" or the "Group"), a closed-end investment company incorporated in the Cayman Islands admitted to trading on the AIM market of the London Stock Exchange, today announces its results for the year ended 31 December 2015.

 

Copies of the Company's annual report will today be posted to shareholders. The annual report is also available to view on the Company's website http://www.reconstructioncapital2.com.

 

Financial highlights

· The audited net asset value as at 31 December 2015 was EUR0.3736 per share (EUR0.3775 per share as at 31 December 2014), a 1.03% decrease over the year;

· The Directors do not recommend the payment of a dividend.

 

Operational highlights

 

Private Equity Programme

 

RC2 did not make any new investments under its Private Equity Programme, and continued to pursue a number of exits, both from its investee companies as well as from certain assets held by them. The investments held under the Private Equity Programme had a fair value of EUR44.4m at the end of 2015 which was slightly more than the 2014 valuation of EUR44.1m.

 

Trading Programme

 

RC2 reduced its positions in listed equities held under its Trading Programme in 2015. At the end of 2015, RC2's listed equities held under the Trading Programme had a total market value of EUR0.27m (2014: EUR 0.34m). All of the investments held under the Trading Programme were in Romanian equities.

 

For further information, please contact:

 

Reconstruction Capital II Limited

Ion Florescu / Anca Moraru

Tel: +40 21 3167680

 

Grant Thornton UK LLP (Nominated Adviser)

Philip Secrett / Carolyn Sansom

Tel: +44 (0) 20 7383 5100

 

Panmure Gordon (UK) Limited (Broker)

Paul Fincham/Jonathan Becher

Tel: +44 (0) 20 7886 2500

 

 

 

ADVISER'S REPORT

For the year ended 31 December 2015

On 31 December 2015, Reconstruction Capital II Limited ("RC2") had a total audited net asset value ("NAV") of EUR37.4m or EUR0.3736 per share on an undiluted basis, a 1.03% decrease over the year. The fully diluted NAV per share was EUR0.2847, an increase of 1.24% over the year.

At the end of 2015, RC2 had cash and cash equivalents of EUR1.1m. RC2's borrowings, after allocating EUR0.63m of the proceeds from the convertible loan note to equity reserves in accordance with applicable accounting standards, amounted to EUR8.98m, whilst suppliers' liabilities amounted to EUR0.1m.

Private Equity Programme

Apart from acquiring the 7.69% minority stake in Glasro Holding Limited for EUR0.54m in June 2015, RC2 did not make any new investments under its Private Equity Programme, and continued to pursue a number of exits, both from its investee companies as well as from certain assets held by them.

The investments held under the Private Equity Programme had a total fair value of EUR44.4m at the end of 2015 which was slightly more than the 2014 valuation of EUR44.1m. The increase of EUR2.6m in the market value of the Albalact SA holding to EUR12.3m, and in the valuations of Glasro Holdings Limited and Mamaia Hotels SRL investments by EUR1.1m and EUR0.4m, respectively, were offset by the EUR0.4m and EUR 0.6m falls in the valuations of the investments in Top Factoring SRL and Policolor SA, respectively, and the full write-down of the EUR 2.6m equity investment in Klas DOO. In addition to the write off of the equity investment in Klass DOO, a partial provision of EUR0.9m was made against the shareholder loan of EUR 1.5m (including accrued interest).

 

Based on unaudited management accounts, all four investments in Romania (Policolor SA, Top Factoring SRL and its sister company Glasro Holdings Limited, Mamaia Resort Hotels SRL and Albalact SA) generated positive EBITDA, and in the case of Glasro and Albalact free cash flow in the form of dividends.

Trading Programme

RC2 reduced its positions held under the Trading Programme during the year. At the end of 2015, RC2's listed equities held under this programme had a total market value of EUR0.27m (2014: EUR0.34m). All of the investments held under the Trading Programme were in Romanian equities.

Outlook

Both the Romanian and Bulgarian economies reported increases in GDP during 2015 of 3.7% and 3.0%, respectively, and are expected to continue to grow during 2016. Increased private consumption and recovering investment are expected to be the main drivers for Romania's GDP growth in 2016, whilst Bulgaria is expected to benefit from net exports though private consumption will remain subdued. Serbian GDP is also expected to grow in 2016, having achieved modest 0.8% growth in 2015, with the main drivers being relaxation in monetary policy and increase in external demand.

Events after the reporting period

On 28 January 2016 RC2 announced an agreement to sell its 25.4% holding in Albalact SA to Lactalis for estimated proceeds of EUR16.7m, to be finally determined based on its net debt immediately prior to the completion of the transaction. This represents a premium of approximately 36% over the carrying value of the investment at year-end. The closing of this transaction is subject to the fulfilment of a series of conditions precedent, including favourable clearance by the Romanian Competition Council which is expected by 1 June 2016.

New Europe Capital SRL

 

INVESTMENT POLICY

 

Private Equity Programme

Under the Private Equity Programme, the Company takes significant or controlling stakes in companies operating primarily in Romania, Serbia, Bulgaria and neighbouring countries (the "Target Region"). The Company invests in investee companies where it believes New Europe Capital SRL (the "Adviser") can add value by implementing operational and/or financial restructuring over a 3 to 5 year horizon. The Company only makes an investment under the Private Equity Programme if its Adviser believes there is a clear exit strategy available, such as trade sale, break up and subsequent disposal of different divisions or assets, or flotation on a stock exchange.

 

Trading Programme

Under the Trading Programme, the Company aims to generate short and medium term returns by investing such portion of its assets as determined by the Directors from time to time in listed equities and fixed income securities, including convertible and other mezzanine instruments, issued by entities in the Target Region. The Trading Programme differs from the Private Equity Programme in the key respect that the Company will typically not take significant or controlling stakes in investee companies and will typically hold investments for shorter periods of time than investments made under the Private Equity Programme.

 

Value Creation

Under its Private Equity Programme, the Adviser is involved at board level in the investee company to seek to implement operational and financial changes to enhance returns. As part of the Company's pre-acquisition due diligence, the Adviser seeks to identify specific actions that it believes will create value in the target investee company post acquisition and, where appropriate, seek to work with third party professionals to develop, in combination with the proposed management team of the target, a value creation plan with clear and identifiable short and medium term targets. These plans are likely to address different parts of the business and are tailored to reflect the specific challenges of the relevant target company. The Adviser believes that the investment strategies under the Private Equity and Trading Programme can achieve returns which are different than the returns of the relevant market indices.

 

Investing Restrictions and Cross-Holdings

The Directors and the Adviser have sought to ensure that the portfolio of investments is sufficiently diversified to spread the risks of those investments. The Investment Strategy does not restrict the Company from investing in other closed-ended funds operating in the Target Region. In line with the Company's investment policy, the Board does not normally authorise any investment in a single investee company that is greater than 20% of the Company's net asset value at the time of effecting the investment and in no circumstances will it approve an investment in a single investee company that is greater than 25% of the Company's net asset value at the time of effecting the investment.

 

Change of investment objective and policy of the Company

Following the annual general meeting of the Company on 14 December 2012, the investment objective and policy of the Company were amended such that no new investments will be made. Further investments into existing portfolio companies will be permitted in certain circumstances pending their realisation and, following each realisation, all proceeds will be returned to Shareholders after paying outstanding liabilities and setting aside a sufficient amount for working capital purposes.

 

Gearing

The Company may borrow up to a maximum level of 30% of its gross assets (as defined in its articles).

 

Distribution Policy

The Company's investment objective is focused principally on the provision of capital growth. For further details of the Company's distribution policy, please refer to the Admission Document on the Company's website. 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

For the year ended 31 December 2015

 

2015

2014

EUR

EUR

Investment income

(Loss)/gain on revaluation of investments at fair value through

(148,934)

4,747,123

profit or loss

Gain on disposal of investments

176,627

-

Interest income

99,583

104,949

Dividend income

2,404,456

1,527,111

Other income

29,232

140,883

Total investment income

2,560,964

6,520,066

Expenses

(892,639)

-

Impairment on loan receivables

Operating expenses

(1,058,837)

(1,405,276)

Total expenses

(1,951,476)

(1,405,276)

Operating profit

609,488

5,114,790

Financial expenses

(977,294)

(889,739)

(Loss)/profit before taxation

(367,806)

4,225,051

Income tax expense

(697)

(14,713)

(Loss)/profit for the year from continuing operations

(368,503)

4,210,338

Loss for the year from discontinued operations

(43,104)

-

(Loss)/profit for the year

(411,607)

4,210,338

Other comprehensive income

Amounts that may be reclassified to profit or loss

-

19,129

Exchange differences on translating foreign operations

Total comprehensive (loss)/income for the year

(411,607)

4,229,467

(Loss)/profit for the year attributable to:

 (371,941)

4,241,776

- Equity holders of the parent

- Non-controlling interest

(39,666)

(31,438)

 (411,607)

4,210,338

Total comprehensive (loss)/income attributable to:

 (371,941)

4,243,209

- Equity holders of the parent

- from continued operations

(368,503)

4,243,209

- from discontinued operations

(3,438)

- Non-controlling interest

(39,666)

(13,742)

- from continued operations

-

(13,742)

- from discontinued operations

(39,666)

-

(411,607)

4,229,467

 

 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

For the year ended 31 December 2015

 

 

Total earnings Per Share attributable to the equity shareholders of the Company

2015

2014

EUR

EUR

Basic undiluted earnings per share

(0.0037)

0.0424

Fully diluted earnings per share

0.0036

0.0270

Continuing operations earnings Per Share attributable to the equity shareholders of the Company

 

2015

2014

EUR

EUR

Basic undiluted earnings per share

(0.0037)

0.0424

Fully diluted earnings per share

0.0036

0.0270

Discontinued operations earnings Per Share attributable to the equity shareholders of the Company

2015

2014

EUR

EUR

Basic undiluted earnings per share

(0.00003)

-

Fully diluted earnings per share

(0.00002)

-

 

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

As at 31 December 2015

 

2015

2014

EUR

EUR

ASSETS

Non-current assets

-

10,518

Property, plant and equipment

Financial assets at fair value through profit or loss

44,455,046

44,085,288

Loans receivable

616,709

1,409,796

Total non-current assets

45,071,755

45,505,602

Current assets

268,591

342,696

Financial assets at fair value through profit or loss

Trade and other receivables

37,462

276,274

Cash and cash equivalents

1,083,954

768,606

Total current assets

1,390,007

1,387,576

TOTAL ASSETS

46,461,762

46,893,178

LIABILITIES

Current liabilities

123,725

847,194

Trade and other payables

Loans and borrowings

46,490

44,190

Corporation tax payable

-

2,211

Total current liabilities

170,215

893,595

Non-current liabilities

8,934,201

7,976,965

Convertible loan notes

Total non-current liabilities

8,934,201

7,976,965

TOTAL LIABILITIES

9,104,416

8,870,560

NET ASSETS

37,357,346

38,022,618

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION (continued)

 

As at 31 December 2015

 

2015

2014

EUR

EUR

CAPITAL AND RESERVES ATTRIBUTABLE TO

EQUITY HOLDERS

Share capital

1,000,000

1,000,000

Share premium

121,900,310

121,900,310

Retained deficit

(86,172,409)

(85,758,495)

Equity component of convertible loan notes

629,445

629,445

Foreign exchange reserve

-

(26,245)

37,357,346

37,745,015

Non-controlling interests

-

277,603

TOTAL EQUITY

37,357,346

38,022,618

2015

2014

EUR

EUR

Net Asset Value per share

Basic undiluted net asset value per share

0.3736

0.3775

Fully diluted net asset value per share

0.2847

0.2812

 

 

CONSOLIDATED CASH FLOW STATEMENT

 

For the year ended 31 December 2015

 

2015

2014

EUR

EUR

Cash flows from operating activities

(411,607)

4,225,051

(Loss)/profit before taxation

Adjustments for:

-

2,588

Depreciation and amortisation

Loss/(gain) on revaluation of investments at fair value through

148,934

(4,747,123)

profit or loss

Gain on disposal of investments

(176,627)

-

Loss for the year from discontinued operations

43,104

-

Impairment on loans receivable

892,639

-

Interest income

(99,583)

(104,949)

Financial expenses

977,294

889,739

Dividend income

(2,403,759)

(1,527,111)

Net loss on foreign exchange

5,200

-

Net cash outflow before changes in working capital

(1,024,405)

(1,261,805)

Increase in trade and other receivables

2,043

68,870

Decrease in trade and other payables

(391,140)

(3,990,128)

Purchase of financial assets

(535,000)

-

Sale of financial assets

267,040

-

Interest income received

45

387

Dividends received

2,403,759

1,526,708

Income tax paid

-

(14,666)

Net cash flows from continuing activities

722,342

(3,670,634)

Net cash flows from discontinued activities

20,296

-

Net cash used by operating activities

742,638

(3,670,634)

Cash flows from investing activities

-

(2,059)

Purchase of property, plant and equipment

Proceeds from loans granted to unconsolidated subsidiaries

-

594,943

Net cash flow generated from investing activities

-

592,884

Cash flows from financing activities

-

(4,256,045)

Payments of loans granted by related parties

Dividends paid to non-controlling interests

-

(96,864)

Proceeds from the issuance of convertible loan notes

-

8,449,999

Interest paid

(237,274)

(622,255)

Net cash flow generated from financing activities

(237,274)

3,474,835

Net increase in cash and cash equivalents before currency adjustment

505,364

397,085

Effects of exchange rate differences on cash and cash equivalents

(67,877)

21,379

Net increase in cash and cash equivalents after currency adjustment

437,487

418,464

Cash and cash equivalents at the beginning of the year

768,606

350,142

Cash and cash equivalents included in discontinued operations

(122,139)

-

Cash and cash equivalents at the end of the year

1,083,954

768,606

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACSXKLFLQZFLBBX
Date   Source Headline
19th Dec 20237:00 amRNSCancellation - Reconstruction Capital II Limited
18th Dec 20237:00 amRNSDelisting and cancellation of trading
15th Dec 20233:32 pmRNSShare Dealing
12th Dec 20239:57 amRNSShare Dealing
8th Dec 202310:40 amRNSShare Dealing
29th Nov 202312:10 pmRNSResult of AGM
21st Nov 20239:34 amRNSShare Dealing
13th Nov 20234:21 pmRNSQuarterly Update
1st Nov 20237:00 amRNSProposed Cancellation & AGM Notice
31st Oct 202310:46 amRNSNet Asset Value and Policolor Material Error
28th Sep 202312:56 pmRNSLoan to Telecredit IFN S.A.
30th Aug 20239:46 amRNSInterim Unaudited Financial Statements
8th Aug 20232:45 pmRNSQuarterly Update
20th Jul 20239:21 amRNSNet Asset Value
23rd Jun 20235:00 pmRNSLoans to Telecredit IFN S.A.
9th Jun 202312:03 pmRNSAnnual Report and Audited Financial Statements
16th May 202311:25 amRNSNet Asset Value and Quarterly Report
11th Apr 20233:44 pmRNSNet Asset Value and Quarterly Report
30th Mar 20238:44 amRNSNew Valuations of Private Equity Positions
9th Jan 202312:38 pmRNSDirector Dealing
15th Dec 20228:59 amRNSLoan Facility
14th Nov 20224:59 pmRNSExtension of maturity date of loans to Telecredit
9th Nov 202212:56 pmRNSQuarterly Update
8th Nov 202211:34 amRNSJudgment in litigation against Romar
20th Oct 202211:31 amRNSNet Asset Value and Quarterly Report
5th Sep 202211:27 amRNSTransaction in Own Shares
17th Aug 20223:28 pmRNSInterim Unaudited Financial Statements
12th Aug 20223:55 pmRNSQuarterly Update
26th Jul 20222:23 pmRNSNet Asset Value
15th Jun 20227:00 amRNSAnnual Report and Audited Financial Statements
17th May 20222:56 pmRNSQuarterly Report
11th May 20222:43 pmRNSTransaction in Own Shares
10th May 20227:46 amRNSExtension of the maturity date of loans
4th May 20222:49 pmRNSNet Asset Value
14th Apr 202212:00 pmRNSNet Asset Value and Quarterly Report
6th Apr 202210:04 amRNSNew Valuations of Private Equity Positions
22nd Dec 20211:54 pmRNSLoans to Telecredit IFN S.A.
16th Nov 202110:06 amRNSQuarterly Report
16th Nov 20219:55 amRNSLoans to Telecredit IFN S.A.
20th Oct 202111:32 amRNSSeptember 2021 NAV Announcement
18th Oct 202112:14 pmRNSLoans to Telecredit IFN S.A.
9th Sep 20212:28 pmRNSDirector Appointment
17th Aug 20217:00 amRNSInterim Unaudited Financial Statements
9th Aug 20211:51 pmRNSQuarterly Report
28th Jul 20212:05 pmRNSNAV Announcement
28th Jul 20212:04 pmRNSDirector Resignation
7th Jun 202112:29 pmRNSAnnual Financial Report
11th May 20211:19 pmRNSQuarterly Report
11th May 20218:42 amRNSLoans to Telecredit IFN S.A.
4th May 202111:01 amRNSNet Asset Value

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.